HAMP and plasma cell myeloma: The concentration of hepcidin increases in many cancers such as myeloma, Hodgkin’s disease, breast, prostate, thyroid, and non-small-cell lung cancers (NSCLC), but also in other solid tumors [33,40,82,103,106,115].